Home > About Us > Leadership > Measure Evaluation Criteria
Click here to login to the members area.
Performance measures are endorsed as national voluntary consensus standards through NQF’s consensus development process . The evaluation criteria used to evaluate measures are an important part of the consensus development process and ensure that NQF endorsement remains the gold standard for measuring healthcare quality. Resources and detailed information about the process NQF follows to evaluate measures can be found on this page.
Measures submitted to NQF are evaluated by a project Steering Committee and technical experts , NQF membership, the NQF Consensus Standards Approval Committee (CSAC), and the NQF Board of Directors .
For consideration by NQF, measures must meet the following conditions:
Measures that meet these conditions and are determined to be in scope for a current NQF project are evaluated against the following recently updated criteria:
Importance to Measure and Report
Scientific Acceptability of Measure Properties
Usability
Feasibility
More information on NQF’s recently updated measure evaluation criteria:
Submitting measures
Before submitting measures for consideration for NQF endorsement, measure developers should review the revised measure evaluation criteria.
Resources for submission of measures to NQF:
Resources for NQF Member Organizations:
In addition to consulting NQF’s measure evaluation criteria, there are a variety of resources NQF member organizations can use prior to voting for measures proposed for endorsement:
1NQF requires any organization submitting a measure for endorsement to execute an intellectual property agreement that addresses disclosure of the measure’s proprietary components, including but not limited to specifications, risk adjustment methodologies, data collection instrument, data collection or analysis software, and database access. For details, please visit http://www.qualityforum.org/pdf/proprietary_policy.pdf
2
NQF requires any measure considered for endorsement to have an identified responsible entity and process to maintain and update the measure on a schedule commensurate with clinical innovation, but at least every 3 years.
3Measures that have not been tested are only potentially eligible for a time-limited endorsement and in that case, measure owners must verify that testing will be completed within 24 months of endorsement.